Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy - a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer

Author: van der Kwast T.H.   Tetu B.   Candas B.   Gomez J.-L.   Cusan L.   Labrie F.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.53, Iss.3, 1999-03, pp. : 523-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content